These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27167679)

  • 1. Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension.
    Ma Z; Mao L; Rajagopal S
    J Vis Exp; 2016 Apr; (110):. PubMed ID: 27167679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.
    Okumura K; Kato H; Honjo O; Breitling S; Kuebler WM; Sun M; Friedberg MK
    J Mol Med (Berl); 2015 Jun; 93(6):663-74. PubMed ID: 25595602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamics and right-ventricle functional characteristics of a swine carotid artery-jugular vein shunt model of pulmonary arterial hypertension: An 18-month experimental study.
    Wu J; Luo X; Huang Y; He Y; Li Z
    Exp Biol Med (Maywood); 2015 Oct; 240(10):1362-72. PubMed ID: 25595189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired left ventricular mechanics in pulmonary arterial hypertension: identification of a cohort at high risk.
    Hardegree EL; Sachdev A; Fenstad ER; Villarraga HR; Frantz RP; McGoon MD; Oh JK; Ammash NM; Connolly HM; Eidem BW; Pellikka PA; Kane GC
    Circ Heart Fail; 2013 Jul; 6(4):748-55. PubMed ID: 23709658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.
    Joshi SR; Dhagia V; Gairhe S; Edwards JG; McMurtry IF; Gupte SA
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H689-98. PubMed ID: 27422986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
    Budas GR; Boehm M; Kojonazarov B; Viswanathan G; Tian X; Veeroju S; Novoyatleva T; Grimminger F; Hinojosa-Kirschenbaum F; Ghofrani HA; Weissmann N; Seeger W; Liles JT; Schermuly RT
    Am J Respir Crit Care Med; 2018 Feb; 197(3):373-385. PubMed ID: 28910144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.
    Lahm T; Frump AL; Albrecht ME; Fisher AJ; Cook TG; Jones TJ; Yakubov B; Whitson J; Fuchs RK; Liu A; Chesler NC; Brown MB
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L375-88. PubMed ID: 27288487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
    Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
    Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Characterization of Cardiac Adaptation and Myocardial Fibrosis in Pulmonary Hypertension Secondary to Systemic-To-Pulmonary Shunt.
    Pereda D; García-Lunar I; Sierra F; Sánchez-Quintana D; Santiago E; Ballesteros C; Encalada JF; Sánchez-González J; Fuster V; Ibáñez B; García-Álvarez A
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27601365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
    Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension reduces energy efficiency of right, but not left, rat ventricular trabeculae.
    Pham T; Nisbet L; Taberner A; Loiselle D; Han JC
    J Physiol; 2018 Apr; 596(7):1153-1166. PubMed ID: 29363144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity interval training, but not continuous training, reverses right ventricular hypertrophy and dysfunction in a rat model of pulmonary hypertension.
    Brown MB; Neves E; Long G; Graber J; Gladish B; Wiseman A; Owens M; Fisher AJ; Presson RG; Petrache I; Kline J; Lahm T
    Am J Physiol Regul Integr Comp Physiol; 2017 Feb; 312(2):R197-R210. PubMed ID: 27784688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RV pressure overload: from hypertrophy to failure.
    van der Bruggen CEE; Tedford RJ; Handoko ML; van der Velden J; de Man FS
    Cardiovasc Res; 2017 Oct; 113(12):1423-1432. PubMed ID: 28957530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage‑dependent changes of β2‑adrenergic receptor signaling in right ventricular remodeling in monocrotaline‑induced pulmonary arterial hypertension.
    Sun F; Lu Z; Zhang Y; Geng S; Xu M; Xu L; Huang Y; Zhuang P; Zhang Y
    Int J Mol Med; 2018 May; 41(5):2493-2504. PubMed ID: 29393391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
    Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
    Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene.
    Said SI; Hamidi SA; Dickman KG; Szema AM; Lyubsky S; Lin RZ; Jiang YP; Chen JJ; Waschek JA; Kort S
    Circulation; 2007 Mar; 115(10):1260-8. PubMed ID: 17309917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
    Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
    J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension.
    Zungu-Edmondson M; Shults NV; Wong CM; Suzuki YJ
    Cardiovasc Res; 2016 May; 110(1):30-9. PubMed ID: 26790474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.